ACET logo

Adicet Bio (ACET) Non Current Assets

Annual Non Current Assets

$45.02 M
-$24.63 M-35.36%

December 31, 2023


Summary


Performance

ACET Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACETbalance sheetmetrics:

Quarterly Non Current Assets

$39.65 M
-$843.00 K-2.08%

September 30, 2024


Summary


Performance

ACET Quarterly Non Current Assets Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACETbalance sheetmetrics:

Non Current Assets Formula

Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets

ACET Non Current Assets Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-35.4%-16.3%
3 y3 years-15.8%-16.3%
5 y5 years--16.3%

ACET Non Current Assets Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-35.4%at low-43.5%at low
5 y5-year-35.4%+158.7%-43.5%+127.8%
alltimeall time-92.0%+878.8%-43.5%+127.8%

Adicet Bio Non Current Assets History

DateAnnualQuarterly
Sep 2024
-
$39.65 M(-2.1%)
Jun 2024
-
$40.49 M(-5.3%)
Mar 2024
-
$42.74 M(-5.1%)
Dec 2023
$162.27 M(-37.8%)
$45.02 M(-5.0%)
Sep 2023
-
$47.37 M(-31.3%)
Jun 2023
-
$68.98 M(-1.7%)
Mar 2023
-
$70.17 M(+0.7%)
Dec 2022
$261.04 M(-7.6%)
$69.65 M(+1.6%)
Sep 2022
-
$68.57 M(+4.2%)
Jun 2022
-
$65.82 M(+11.7%)
Mar 2022
-
$58.92 M(+4.3%)
Dec 2021
$282.44 M(+181.5%)
$56.50 M(-2.9%)
Sep 2021
-
$58.17 M(+10.9%)
Jun 2021
-
$52.48 M(-0.9%)
Mar 2021
-
$52.97 M(-1.0%)
Dec 2020
$100.34 M(+56.3%)
$53.50 M(+62.2%)
Sep 2020
-
$32.99 M(+89.6%)
Dec 2019
$64.19 M(-87.2%)
$17.40 M
Jun 2018
$502.63 M(+3.0%)
-
Jun 2017
$488.15 M(+39.5%)
-
Jun 2016
$350.06 M(+12.8%)
-
Jun 2015
$310.31 M(+12.3%)
-
Jun 2014
$276.35 M(+26.6%)
-
Jun 2013
$218.30 M(+13.7%)
-
Jun 2012
$191.97 M(-3.3%)
-
Jun 2011
$198.62 M(+1.6%)
-
DateAnnualQuarterly
Jun 2010
$195.55 M(+13.9%)
-
Jun 2009
$171.65 M(-11.4%)
-
Jun 2008
$193.78 M(+20.3%)
-
Jun 2007
$161.03 M(+14.1%)
-
Jun 2006
$141.11 M(+7.2%)
-
Jun 2005
$131.64 M(-1.0%)
-
Jun 2004
$132.97 M(+20.6%)
-
Jun 2003
$110.25 M(+9.5%)
-
Jun 2002
$100.72 M(+11.2%)
-
Jun 2001
$90.56 M(+22.6%)
-
Jun 2000
$73.84 M(+5.5%)
-
Jun 1999
$70.00 M(-6.4%)
-
Jun 1998
$74.80 M(+1.9%)
-
Jun 1997
$73.40 M(+0.1%)
-
Jun 1996
$73.30 M(+1.9%)
-
Jun 1995
$71.90 M(+9.4%)
-
Jun 1994
$65.70 M(+4.1%)
-
Jun 1993
$63.10 M(-8.0%)
-
Jun 1992
$68.60 M(+5.7%)
-
Jun 1991
$64.90 M(+3.0%)
-
Jun 1990
$63.00 M(+2.1%)
-
Jun 1989
$61.70 M(+5.7%)
-
Jun 1988
$58.40 M(-6.4%)
-
Jun 1987
$62.40 M(+11.6%)
-
Jun 1986
$55.90 M(+10.7%)
-
Jun 1985
$50.50 M(+6.5%)
-
Jun 1984
$47.40 M
-

FAQ

  • What is Adicet Bio annual long term assets?
  • What is the all time high annual non current assets for Adicet Bio?
  • What is Adicet Bio annual non current assets year-on-year change?
  • What is Adicet Bio quarterly long term assets?
  • What is the all time high quarterly non current assets for Adicet Bio?
  • What is Adicet Bio quarterly non current assets year-on-year change?

What is Adicet Bio annual long term assets?

The current annual non current assets of ACET is $45.02 M

What is the all time high annual non current assets for Adicet Bio?

Adicet Bio all-time high annual long term assets is $566.63 M

What is Adicet Bio annual non current assets year-on-year change?

Over the past year, ACET annual long term assets has changed by -$24.63 M (-35.36%)

What is Adicet Bio quarterly long term assets?

The current quarterly non current assets of ACET is $39.65 M

What is the all time high quarterly non current assets for Adicet Bio?

Adicet Bio all-time high quarterly long term assets is $70.17 M

What is Adicet Bio quarterly non current assets year-on-year change?

Over the past year, ACET quarterly long term assets has changed by -$7.73 M (-16.31%)